IARC revised its carcinogenicity evaluations website (Volumes 1-123)

25 February, 2019.
(Revised 8 March, 2019.)

The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization, revised its carcinogenicity evaluations website on February 22, 2019.
https://monographs.iarc.fr/agents-classified-by-the-iarc/

This revision is to notify publication of the online version of "IARC Monographs Volume 119: Some Chemicals That Cause Tumours of the Urinary Tract in Rodents".
http://publications.iarc.fr/575

There is no new agent added, and no change in the carcinogenicity categories for existing agents including EMFs.

Note by JEIC:
Following update of IARC Monographs Preamble and elimination of classification of "Group 4: Probably not carcinogenic to humans", Caprolactam, only one agent formerly classified as Group 4, was moved to "Group 3: Not classifiable as to its carcinogenicity to humans".
Related information:
https://www.jeic-emf.jp/english/academic/info/6599.html